(1S,2S)-2-[4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylamino]phenyl]-N-propan-2-ylcyclopropane-1-carboxamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (1S,2S)-2-[4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylamino]phenyl]-N-propan-2-ylcyclopropane-1-carboxamide
• 化学式: C₂₅H₂₆F₃N₃OS
• 分子量: 473.562
• InChiKey: BZBFVTWEYHYWAY-RTWAWAEBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  33
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  82.3
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  4-硝基苯乙烯 在 sodium hydroxide 、 Na(OAc)3H 、 (CuOTf)*toluene 、 2,2'-diisopropylidenebis[(4R)-4-tert-butyl-2-oxazoline] 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 四氢呋喃 、 乙醇 、 氯仿 、 1,2-二氯乙烷 、 N,N-二甲基甲酰胺 为溶剂， 20.0 ℃ 、6.67 kPa 条件下， 反应 16.0h， 生成 (1S,2S)-2-[4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylamino]phenyl]-N-propan-2-ylcyclopropane-1-carboxamide
  参考文献：
  名称：

  Synthesis and activity of small molecule GPR40 agonists

  摘要：

  The first report on the identification and structure-activity relationships of a novel series of GPR40 agonists based on a 3(4-{[N-alkyl]amino phenyl)propanoic acid template is described. Structural modifications to the original screening hit yielded compounds with a 100-fold increase in potency at the human GPR40 receptor and pEC(50)s in the low nanomolar range. The carboxylic acid moiety is not critical for activity but typically elicits an agonistic response higher than those observed with carboxamide replacements. These compounds may prove useful in unraveling the therapeutic potential of this receptor for the treatment of Type 2 diabetes. (C) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.01.007

文献信息

• [EN] AMINOPHENYLCYCLOPROPYL CARBOXYLIC ACIDS AND DERIVATIVES AS AGONISTS TO GPR40<br/>[FR] ACIDES AMINOPHENYLCYCLOPROPYLCARBOXYLIQUES ET LEURS DERIVES SERVANT D'AGONISTES DE GPR40
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2005051890A1

  公开（公告）日：2005-06-09

  The present invention relates generally to novel therapeutic compounds and more particularly to novel compounds, their use as GPR40 agonists, processes for their manufacture, and intermediates useful in their preparation.

  本发明一般涉及新型治疗化合物，更具体地涉及新型化合物，它们作为GPR40激动剂的用途，它们的制造工艺以及在它们的制备中有用的中间体。
• Synthesis and activity of small molecule GPR40 agonists
  作者：Dulce M. Garrido、David F. Corbett、Kate A. Dwornik、Aaron S. Goetz、Thomas R. Littleton、Steve C. McKeown、Wendy Y. Mills、Terrence L. Smalley、Celia P. Briscoe、Andrew J. Peat

  DOI：10.1016/j.bmcl.2006.01.007

  日期：2006.4

  The first report on the identification and structure-activity relationships of a novel series of GPR40 agonists based on a 3(4-[N-alkyl]amino phenyl)propanoic acid template is described. Structural modifications to the original screening hit yielded compounds with a 100-fold increase in potency at the human GPR40 receptor and pEC(50)s in the low nanomolar range. The carboxylic acid moiety is not critical for activity but typically elicits an agonistic response higher than those observed with carboxamide replacements. These compounds may prove useful in unraveling the therapeutic potential of this receptor for the treatment of Type 2 diabetes. (C) 2006 Elsevier Ltd. All rights reserved.